Bank Of America Corp Surmodics Inc Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Surmodics Inc stock. As of the latest transaction made, Bank Of America Corp holds 20,060 shares of SRDX stock, worth $789,561. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,060

Previous 320,360 93.74%

Holding current value

$789,561

Previous $9.4 Million 91.03%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$25.39 - $42.1 $7.62 Million - $12.6 Million	-300,300 Reduced 93.74%	20,060 $843,000
Q1 2024 May 15, 2024	BUY	$27.44 - $35.56 $1.9 Million - $2.46 Million	69,206 Added 27.56%	320,360 $9.4 Million
Q4 2023 Feb 14, 2024	BUY	$28.47 - $38.49 $6.63 Million - $8.96 Million	232,792 Added 1267.79%	251,154 $9.13 Million
Q2 2023 Aug 14, 2023	SELL	$17.67 - $31.31 $115,261 - $204,235	-6,523 Reduced 26.21%	18,362 $574,000
Q1 2023 May 12, 2023	BUY	$17.13 - $38.52 $234,252 - $526,761	13,675 Added 121.99%	24,885 $566,000
Q4 2022 Feb 10, 2023	BUY	$29.44 - $37.31 $161,978 - $205,279	5,502 Added 96.39%	11,210 $382,000
Q3 2022 Nov 14, 2022	SELL	$28.84 - $38.92 $76,483 - $103,215	-2,652 Reduced 31.72%	5,708 $174,000
Q2 2022 Aug 12, 2022	SELL	$33.25 - $45.11 $253,065 - $343,332	-7,611 Reduced 47.66%	8,360 $311,000
Q1 2022 May 16, 2022	SELL	$40.68 - $49.72 $321,575 - $393,036	-7,905 Reduced 33.11%	15,971 $723,000
Q4 2021 Feb 08, 2022	BUY	$43.21 - $57.6 $368,408 - $491,097	8,526 Added 55.54%	23,876 $1.15 Million
Q3 2021 Nov 15, 2021	BUY	$52.8 - $60.32 $181,368 - $207,199	3,435 Added 28.83%	15,350 $853,000
Q2 2021 Sep 13, 2021	BUY	$51.29 - $59.15 $611,120 - $704,772	11,915 New	11,915 $646,000

Others Institutions Holding SRDX

# of Institutions

124

Shares Held

13.2M

Call Options Held

25.5K

Put Options Held

3.4K

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $551M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Surmodics Inc Transaction History